Pulxion is dedicated to the development of early detection technologies for diseases, providing rapid, accurate, and convenient disease detection and health guidance to achieve preventive healthcare and safeguard the health of the general public.

Stroke is a global health issue and has consistently ranked as one of the top five leading causes of death in many countries worldwide. According to the data from various health organizations and government sources, there are approximately 12.2 million new cases of stroke globally from which over 6 million people die each year, bringing a significant burden on the healthcare system and public health. These statistics demonstrate the global impact of stroke as a major health issue, underscoring the importance of effective preventive measures and early detection technologies to reduce the incidence and mortality associated with stroke on a global scale. 

Prof. Herbert Hsiao, the founder of Pulxion Medical Technology, pointed out that there are early indicators (such as carotid artery stenosis) for stroke that can be detected before occurrence. However, the current diagnosis methods usually involve long waiting process and require professional operators as well as interpretation, which greatly impact the popularization and implementation of early screening. Pulxion Medical Technology will soon launch the "PulStroke®", featuring rapid, accurate, and cost-effective screening technology for carotid artery stenosis to enhance the early detection rate, leading to better overall public health.